Product Images Capecitabine
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 9 images provide visual information about the product associated with Capecitabine NDC 69097-948 by Cipla Usa Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
42a74ac9 e32a 4b9a 800f 1d3d5fdfc000 01
42a74ac9 e32a 4b9a 800f 1d3d5fdfc000 02
42a74ac9 e32a 4b9a 800f 1d3d5fdfc000 03
42a74ac9 e32a 4b9a 800f 1d3d5fdfc000 04
42a74ac9 e32a 4b9a 800f 1d3d5fdfc000 05
Not available.*
42a74ac9 e32a 4b9a 800f 1d3d5fdfc000 06
42a74ac9 e32a 4b9a 800f 1d3d5fdfc000 07
42a74ac9 e32a 4b9a 800f 1d3d5fdfc000 08
NDC 69097-949-03 is a prescription drug called Capecitabine. It is available in the form of film-coated tablets, USP. Each tablet contains 150 mg of capecitabine. The usual dosage and storage instructions can be found in the package insert. The tablets should be stored at a temperature of 25°C (77°F) with excursions permitted between 15°-30°C (59°-86°F). It should be kept tightly closed in tight containers as defined in USP/NF. The drug is manufactured by MSN Laboratories Private Limited in Telangana, India, and distributed by Cipla USA, Inc. The revision date of the information is 09/07/2019. Additional details including GTIN, SIN, EXP, and LOT are over coded with 2D during packing in a coding area measuring 38 x 25 mm.*
42a74ac9 e32a 4b9a 800f 1d3d5fdfc000 09
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.